HRP20030729A2 - Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency encoded glycoprotein - Google Patents
Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency encoded glycoproteinInfo
- Publication number
- HRP20030729A2 HRP20030729A2 HR20030729A HRP20030729A HRP20030729A2 HR P20030729 A2 HRP20030729 A2 HR P20030729A2 HR 20030729 A HR20030729 A HR 20030729A HR P20030729 A HRP20030729 A HR P20030729A HR P20030729 A2 HRP20030729 A2 HR P20030729A2
- Authority
- HR
- Croatia
- Prior art keywords
- epitope
- monoclonal antibody
- antibody specific
- feline immunodeficiency
- encoded glycoprotein
- Prior art date
Links
- 241000282324 Felis Species 0.000 title 1
- 102000003886 Glycoproteins Human genes 0.000 title 1
- 108090000288 Glycoproteins Proteins 0.000 title 1
- 206010061598 Immunodeficiency Diseases 0.000 title 1
- 208000029462 Immunodeficiency disease Diseases 0.000 title 1
- 230000007813 immunodeficiency Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41024602P | 2002-09-12 | 2002-09-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20030729A2 true HRP20030729A2 (en) | 2005-02-28 |
Family
ID=31888412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20030729A HRP20030729A2 (en) | 2002-09-12 | 2003-09-11 | Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency encoded glycoprotein |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7345152B2 (pt) |
| EP (2) | EP2281838A1 (pt) |
| JP (1) | JP4472298B2 (pt) |
| KR (1) | KR101114268B1 (pt) |
| CN (1) | CN1528791B (pt) |
| AR (1) | AR041230A1 (pt) |
| AT (1) | ATE553126T1 (pt) |
| AU (2) | AU2003246049A1 (pt) |
| BR (1) | BR0303500B1 (pt) |
| CO (1) | CO5500021A1 (pt) |
| CY (1) | CY1112710T1 (pt) |
| DK (1) | DK1398325T3 (pt) |
| ES (1) | ES2383075T3 (pt) |
| HR (1) | HRP20030729A2 (pt) |
| MX (1) | MXPA03008083A (pt) |
| NZ (1) | NZ528160A (pt) |
| PL (1) | PL362164A1 (pt) |
| PT (1) | PT1398325E (pt) |
| RS (1) | RS51739B (pt) |
| SI (1) | SI1398325T1 (pt) |
| TW (1) | TW200406421A (pt) |
| ZA (1) | ZA200307119B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1624785B1 (en) | 2003-01-17 | 2013-07-17 | Aethlon Medical, Inc. | Method for removal of viruses from blood by lectin affinity hemodialysis |
| CN102735853B (zh) * | 2012-06-07 | 2014-06-04 | 广州市华南农大生物药品有限公司 | 一种猪流感灭活疫苗的效价测定方法 |
| RU2018123480A (ru) * | 2015-12-23 | 2020-01-24 | Интервет Интернэшнл Б.В. | Вакцина против кошачьего калицивируса |
| CN110501509A (zh) * | 2019-09-03 | 2019-11-26 | 长春西诺生物科技有限公司 | 一种抗猫细小病毒猫源化基因工程抗体elisa试剂盒及其检测方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6107077A (en) * | 1987-08-26 | 2000-08-22 | Yamamoto; Janet K. | Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines |
| CA1341439C (en) * | 1987-08-26 | 2003-09-23 | Niels C. Pedersen | Feline t-lymphotropic lentivirus |
| US5219725A (en) * | 1988-12-05 | 1993-06-15 | Idexx Laboratories Incorporated | Monoclonal antibodies to feline-t-lymphotropic lentivirus |
| US5177014A (en) * | 1988-12-05 | 1993-01-05 | Idexx Laboratories, Inc. | Monoclonal antibodies to feline-T-lymphotropic lentivirus |
| US6228608B1 (en) | 1991-02-28 | 2001-05-08 | Aquila Biopharmaceuticals, Inc. | Recombinant FIV glycoprotein 160 and P24 gag protein |
| GB9215233D0 (en) | 1992-07-17 | 1992-09-02 | Pitman Moore Inc | Vaccines |
| WO1994020622A1 (en) | 1993-03-11 | 1994-09-15 | Akzo Nobel N.V. | Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus |
| US6015686A (en) * | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
| US6254872B1 (en) | 1995-08-25 | 2001-07-03 | University Of Florida | Multi-subtype FIV vaccines |
| ATE313629T1 (de) | 1998-08-24 | 2006-01-15 | Pfizer Prod Inc | Immunschwächevirus stamm fiv-141 der katze und dessen verwendungen |
-
2003
- 2003-08-26 US US10/648,667 patent/US7345152B2/en not_active Expired - Lifetime
- 2003-09-08 MX MXPA03008083A patent/MXPA03008083A/es active IP Right Grant
- 2003-09-08 KR KR1020030062762A patent/KR101114268B1/ko not_active IP Right Cessation
- 2003-09-09 CO CO03078836A patent/CO5500021A1/es not_active Application Discontinuation
- 2003-09-10 SI SI200332137T patent/SI1398325T1/sl unknown
- 2003-09-10 ES ES03255660T patent/ES2383075T3/es not_active Expired - Lifetime
- 2003-09-10 DK DK03255660.7T patent/DK1398325T3/da active
- 2003-09-10 EP EP10183768A patent/EP2281838A1/en not_active Withdrawn
- 2003-09-10 AT AT03255660T patent/ATE553126T1/de active
- 2003-09-10 JP JP2003318535A patent/JP4472298B2/ja not_active Expired - Fee Related
- 2003-09-10 BR BRPI0303500-0B1A patent/BR0303500B1/pt not_active IP Right Cessation
- 2003-09-10 EP EP03255660A patent/EP1398325B1/en not_active Expired - Lifetime
- 2003-09-10 PT PT03255660T patent/PT1398325E/pt unknown
- 2003-09-11 CN CN031649092A patent/CN1528791B/zh not_active Expired - Fee Related
- 2003-09-11 NZ NZ528160A patent/NZ528160A/en not_active IP Right Cessation
- 2003-09-11 ZA ZA2003/07119A patent/ZA200307119B/en unknown
- 2003-09-11 AR ARP030103289A patent/AR041230A1/es active IP Right Grant
- 2003-09-11 HR HR20030729A patent/HRP20030729A2/xx not_active Application Discontinuation
- 2003-09-11 AU AU2003246049A patent/AU2003246049A1/en not_active Abandoned
- 2003-09-12 RS YU71803A patent/RS51739B/sr unknown
- 2003-09-12 TW TW092125182A patent/TW200406421A/zh unknown
- 2003-09-12 PL PL03362164A patent/PL362164A1/xx unknown
-
2010
- 2010-09-22 AU AU2010224370A patent/AU2010224370B2/en not_active Expired
-
2012
- 2012-05-03 CY CY20121100411T patent/CY1112710T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1112710T1 (el) | 2016-02-10 |
| KR20040024490A (ko) | 2004-03-20 |
| ZA200307119B (en) | 2005-05-25 |
| YU71803A (sh) | 2006-05-25 |
| ATE553126T1 (de) | 2012-04-15 |
| EP2281838A1 (en) | 2011-02-09 |
| CN1528791B (zh) | 2012-09-05 |
| PL362164A1 (en) | 2004-03-22 |
| BR0303500A (pt) | 2004-09-08 |
| RS51739B (sr) | 2011-10-31 |
| PT1398325E (pt) | 2012-05-29 |
| ES2383075T3 (es) | 2012-06-18 |
| MXPA03008083A (es) | 2004-11-29 |
| KR101114268B1 (ko) | 2012-03-05 |
| CN1528791A (zh) | 2004-09-15 |
| BR0303500B1 (pt) | 2013-09-17 |
| SI1398325T1 (sl) | 2012-06-29 |
| JP2004097225A (ja) | 2004-04-02 |
| NZ528160A (en) | 2005-07-29 |
| AU2010224370A1 (en) | 2010-10-14 |
| US7345152B2 (en) | 2008-03-18 |
| AR041230A1 (es) | 2005-05-11 |
| CO5500021A1 (es) | 2005-03-31 |
| AU2003246049A1 (en) | 2004-04-01 |
| EP1398325B1 (en) | 2012-04-11 |
| US20040053224A1 (en) | 2004-03-18 |
| TW200406421A (en) | 2004-05-01 |
| JP4472298B2 (ja) | 2010-06-02 |
| EP1398325A1 (en) | 2004-03-17 |
| AU2010224370B2 (en) | 2011-07-21 |
| DK1398325T3 (da) | 2012-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL149820A0 (en) | Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency | |
| HK1153649A1 (zh) | 治療性抗 單克隆抗體 | |
| EP1391464A4 (en) | ANTI-CD40 MONOCLONAL ANTIBODY | |
| CY2012019I2 (el) | Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20 | |
| AU2003264009A8 (en) | Humanized rabbit antibodies | |
| EP1633785A4 (en) | HUMAN MONOCLONAL ANTIBODIES AGAINST BACILLUS ANTHRACIS PROTECTIVE ANTIGEN | |
| AU2002251562A1 (en) | Anti-CD40 monoclonal antibody | |
| DK1366067T3 (da) | Ekspressionsteknologi for proteiner indeholdende en hybrid isotype-antistof-enhed | |
| IL167041A (en) | A method for clearing an antibody that binds to her2 from a preparation that contains the antibody and its deaminated derivative | |
| IS7576A (is) | And-mýelíntengd glýkóprótín (MAG) mótefni | |
| EP1647596A4 (en) | MONOCLONAL ANTIBODY AGAINST GLYCOPROTEIN VI THE BLOOD PLATE MEMBRANE | |
| AU2003220079A8 (en) | Uses of monoclonal antibody 8h9 | |
| HRP20030729A2 (en) | Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency encoded glycoprotein | |
| EP1556499A4 (en) | FOR CARCINOGENIC BACTERIA SPECIFIC MONOCLONAL ANTIBODIES | |
| FI20020807A0 (fi) | Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita | |
| FI20011055A (fi) | Heveiiniä sitovat monoklonaaliset vasta-aineet | |
| EP1559725A4 (en) | ANTIBODY WITH ANTIGENIC RECOGNITION | |
| EP1534827A4 (en) | PROCESS FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES | |
| AU2003236346A1 (en) | Monoclonal antibody neutralizing megsin | |
| AU2002326710A1 (en) | Methods for screening monoclonal antibodies on heterogeneous antigen substrates | |
| EP1446416A4 (en) | TUMOR-SPECIFIC MONOCLONAL ANTIBODIES | |
| AU2003232907A8 (en) | Immunogenic, monoclonal antibody comprising at least 2 different epitopes of a tumor-associated antigen | |
| GB0121727D0 (en) | Monoclonal antibodies | |
| AU2003249403A1 (en) | Polypeptide antigen inducing hiv neutralizing antibodies | |
| AU2003268737A1 (en) | Novel method of constructing monoclonal antibody |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20110831 Year of fee payment: 9 |
|
| ODBI | Application refused |